Brain contains cocaine-like chemical

July 18, 2000

ATLANTA -- July 19, 2000 -- Dr. Michael Kuhar and a team of neuroscientists at the Yerkes Regional Primate Research Center of Emory University have found that a naturally occurring neurotransmitter produces behaviors associated with cocaine and methamphetamine. The finding suggests a role for the brain chemical, called CART (Cocaine- and Amphetamine-Regulated Transcript) peptide, in modulating or mediating the actions of drugs and a perhaps potential new avenue for treating addiction. Funded by a multi-year grant from the National Institute on Drug Abuse, the study will be reported in the August issue (vol. 294, no. 2) of The Journal of Pharmacology and Experimental Therapeutics.

Using rat models, Kuhar and his team injected CART peptide directly into the ventral tegamental area (VTA), a region of the brain stem involved in addiction and feelings of euphoria. The VTA is also one of several areas where the neurotransmitter occurs naturally. In their experiments, the researchers observed increased locomotor activity, comparable to that seen with cocaine administration.

In a separate experiment, Kuhar's team found that the administration of CART peptide caused the rats to return repeatedly to the place where they received the initial injection. The behavior, known as conditioned place preference, has been observed during animal studies on the effects of cocaine on the brain. "CART peptide seems to act as an endogenous cocaine," said Kuhar. "The rats perceived the neurotransmitter as a good feeling and wanted to reinforce that 'euphoria' by returning to the place where they received it."

Given the observed behavioral changes, Kuhar believes CART peptide could somehow influence the psychostimulant effects of cocaine and methamphetamine. Its ability to spur conditioned place preference further suggests a role for the neurotransmitter in the drug addiction process.

Previous studies have identified CART peptide in areas of the brain directly affected by cocaine and methamphetamine. Scientists have also measured increased levels of CART when cocaine was administered.

"This latest discovery about CART's cocaine-like properties gives us a potential therapeutic target for medications designed to treat addiction," said Kuhar. "Theoretically, it might be possible to modulate the neurotransmitter in such a way that craving for cocaine or methamphetamine might be altered."

The next steps will be to ascertain the role of CART peptide in other areas of the brain and possibly extend the studies to primates. As a consequence of animal studies on the effects of cocaine on the brain, scientists have determined that CART peptide also influences hunger, stress, endocrine control, and sensory processing.

In addition to Kuhar, the study's authors include Drs. Heather Kimmel and Wenhe Gong, Stephanie Dall Vechia, and Richard G. Hunter.

A nationally-known expert on the biological underpinnings of drug addiction, Kuhar has also been instrumental in the development of a new class of cocaine analogues called phenyltropanes. Kuhar's colleague at Yerkes, Dr. Leonard Howell, is currently testing the compounds as part of a five-year effort by NIDA and the Office of National Drug Control Policy to develop a medication for treating cocaine addiction.

Cocaine and methamphetamine are the only illicit drugs for which there exists no therapeutic substitute to control craving. An estimated two million Americans use cocaine and methamphetamine.
The Yerkes Regional Primate Research Center is part of the Woodruff Health Sciences Center of Emory University. It is the oldest scientific institution dedicated to primate research. Yerkes' programs cover a wide range of biomedical and behavioral sciences.

Dr. Kuhar can be reached at 404-727-1737 or via email at The abstract of the article can be accessed at

Copies of the full text of the study are available upon request.

Emory University Health Sciences Center

Related Cocaine Articles from Brightsurf:

Sleep-deprived mice find cocaine more rewarding
Sleep deprivation may pave the way to cocaine addiction. Too-little sleep can increase the rewarding properties of cocaine, according to new research in mice published in eNeuro.

Nucleus accumbens recruited by cocaine, sugar are different
In a study using genetically modified mice, a University of Wyoming faculty member found that the nucleus accumbens recruited by cocaine use are largely distinct from nucleus accumbens recruited by sucrose, or table sugar.

Astrocytes build synapses after cocaine use in mice
Drugs of abuse, like cocaine, are so addictive due in part to their cellular interaction, creating strong cellular memories in the brain that promote compulsive behaviors.

Of all professions, construction workers most likely to use opioids and cocaine
Construction workers are more likely to use drugs than workers in other professions, finds a study by the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU College of Global Public Health.

Chronic cocaine use modifies gene expression
Chronic cocaine use changes gene expression in the hippocampus, according to research in mice recently published in JNeurosci.

Blocking dopamine weakens effects of cocaine
Blocking dopamine receptors in different regions of the amygdala reduces drug seeking and taking behavior with varying longevity, according to research in rats published in eNeuro.

Born to run: just not on cocaine
A study finds a surprising response to cocaine in a novel strain of mutant mice -- they failed to show hyperactivity seen in normal mice when given cocaine and didn't run around.

Cocaine adulterant may cause brain damage
People who regularly take cocaine cut with the animal anti-worming agent levamisole demonstrate impaired cognitive performance and a thinned prefrontal cortex.

Setting affects pleasure of heroin and cocaine
Drug users show substance-specific differences in the rewarding effects of heroin versus cocaine depending on where they use the drugs, according to a study published in JNeurosci.

One in 10 people have traces of cocaine or heroin on their fingerprints
Scientists have found that drugs are now so prevalent that 13 percent of those taking part in a test were found to have traces of class A drugs on their fingerprints -- despite never using them.

Read More: Cocaine News and Cocaine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to